SCHEDULE: State Street Corp. Discloses Novavax Stake

State Street Corporation has updated its Schedule 13G filing to reflect beneficial ownership of 7.1% of Novavax Inc. common stock as of June 30, 2026.

Summary

• State Street Corporation has filed a Schedule 13G, indicating a change in its beneficial ownership of Novavax Inc. common stock.
• As of June 30, 2026, State Street Corporation beneficially owns 11,740,566 shares of Novavax Inc. common stock.
• This represents 7.1% of the class of securities.
• The filing is made by State Street Corporation, a Massachusetts-based entity.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of Novavax Inc.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as neutral to slightly negative, as it primarily reports a change in beneficial ownership without providing new operational or financial performance data.

Positives

• State Street Corporation's filing provides transparency regarding its significant beneficial ownership in Novavax Inc.
• The filing confirms that the shares are held in the ordinary course of business, suggesting a passive investment approach.

Negatives

• The filing does not contain any new financial performance data or operational updates for Novavax Inc.
• The information is a routine disclosure of beneficial ownership, offering no new strategic insights into Novavax's business.

Risks

• Potential for future changes in State Street Corporation's ownership stake, which could impact Novavax's stock stability.
• The filing does not address any specific risks related to Novavax's business operations or financial health.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Novavax Inc.'s future performance. It solely reports on current beneficial ownership.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors like State Street Corporation, indicating significant holdings. This filing provides insight into institutional interest in Novavax Inc. but does not reflect the company's operational performance.

Stakeholder Impact

• Shareholders: May view the significant stake held by a large institutional investor as a sign of confidence, or may be concerned about potential future sales impacting share price.
• Creditors: The filing does not directly impact creditors as it pertains to equity ownership and not debt.
• Employees: No direct impact is indicated by this filing.
• Suppliers: No direct impact is indicated by this filing.
• Customers: No direct impact is indicated by this filing.

Next Steps

• State Street Corporation will continue to hold its shares in Novavax Inc. in the ordinary course of business.
• Future filings will be made by State Street Corporation if there are further changes in beneficial ownership that trigger reporting requirements.

Key Dates

Keywords

State Street Corporation, Novavax Inc., Schedule 13G, Beneficial Ownership, Common Stock, Investment Holding